Process validation plays a critical role in ensuring the quality, safety, and consistency of multivitamin tablet formulations across both pharmaceutical and nutraceutical sectors. Despite serving similar end-user needs, these two categories are governed by distinct regulatory frameworks, resulting in divergent validation requirements. This review presents a comparative evaluation of process validation approaches applicable to multivitamin tablets classified as either drugs or nutraceuticals. Key focus areas include differences in regulatory expectations, validation lifecycle stages, identification and control of critical process parameters (CPPs), documentation practices, and the application of quality risk management tools. The review also highlights emerging trends such as digitalization, real-time monitoring, and the adoption of Quality by Design (QbD) principles, particularly in high-risk nutraceuticals. By analyzing these aspects side by side, the article aims to assist quality assurance professionals, regulatory experts, and manufacturers in aligning validation strategies for improved compliance, product uniformity, and consumer safety. The insights provided may also support regulatory harmonization and the development of integrated quality systems across both product categories.
Multivitamin tablets are widely consumed dietary products that serve diverse roles ranging from general nutritional supplementation to therapeutic applications. Their categorization as either a drug or a nutraceutical depends on factors such as composition, intended use, claims, dosage, and regulatory jurisdiction. In India, products classified as drugs are regulated under the Drugs and Cosmetics Act and Rules, while nutraceuticals fall under the purview of the Food Safety and Standards Authority of India (FSSAI)
The present review undertakes a detailed comparison of the process validation requirements for multivitamin tablet formulations in these two categories. The goal is to provide clarity on best practices, expectations, and critical differences, ultimately contributing to effective compliance and assurance of product quality.
Process validation (PV) is a documented, evidence-based activity that establishes a high level of assurance that a specific process consistently produces a product meeting its pre-determined specifications and quality attributes
The critical objectives of PV include
Ensuring reproducibility and uniformity of product characteristics.
Identification and control of critical process parameters (CPPs).
Enhancing regulatory compliance and operational efficiency.
Mitigating risk through early identification of deviations.
Governed by stringent regulations like US FDA 21 CFR Part 210/211
ICH Guidelines Q8 (Pharmaceutical Development), Q9 (Quality Risk Management), and Q10 (Pharmaceutical Quality System) form the backbone of modern process validation principles
Emphasis on lifecycle approach to validation including Process Design, Process Qualification, and Continued Process Verification (CPV)
Requirement of three consecutive successful batches during Process Performance Qualification (PPQ)
Governed under FSSAI notifications
PV requirements are relatively flexible; however, there is increasing emphasis on validation of sanitation, hygiene, CCPs (Critical Control Points), and product consistency
Blending: Uniformity of micronutrient distribution; risk of segregation in low-dose vitamins
Granulation: Control of binder levels, mixing time, and granule homogeneity (especially critical in hygroscopic or thermo-labile vitamins)
Drying: End-point moisture critical to tablet stability
Compression: Weight variation, hardness, friability—all influencing dissolution and stability
Coating: Film uniformity, visual appearance, moisture protection (especially for B-complex vitamins)
Use of statistically designed experiments (DoE) to define design space
Validation of analytical methods (e.g., HPLC, UV for vitamin quantification)
Cleaning validation to avoid cross-contamination
Strict traceability and deviation management
Consistency of ingredient mixing (especially natural or herbal components)
Validation of hygienic design and cleaning protocols
Label claim validation (e.g., vitamin levels till end of shelf life)
Use of metal detectors, sieves, and environmental monitoring as part of PRPs (Prerequisite Programs)
|
|
|
|
|
Stage 1: Process Design |
Based on Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), and risk assessment (FMEA) |
Based on product profile, hazard analysis, and risk categorization (HACCP, VACCP) |
|
Stage 2: Process Qualification |
Detailed IQ, OQ, and PPQ; Use of conformance batches and statistical process control |
Equipment and sanitation validation, control of CCPs and PRPs |
|
Stage 3: Continued Process Verification (CPV) |
Ongoing batch monitoring, trending of CPPs and CQAs, annual product quality review |
Periodic internal audits, sanitation record review, control of deviations |
Validation Master Plan (VMP), individual validation protocols and reports
Use of control charts, process capability indices - Cp (Process Capability) & Cpk (Process Capability Index), regression models
Documentation required for every process change, deviation, or revalidation trigger
FSMS Manual, PRP validation records, SOPs, and cleaning logs
Use of checklists and verification records instead of statistical analysis
Less emphasis on predictive statistics, though trending is encouraged
High cost of compliance and analytical testing
Need for real-time monitoring tools (PAT)
Managing process drift across global manufacturing sites
Heterogeneity of raw materials (especially botanical extracts)
Lack of harmonized global regulations
Limited technical expertise in small-scale nutraceutical firms
Convergence of quality systems under risk-based models
Use of Quality by Design (QbD) principles in high-risk nutraceuticals
Implementation of digital twins, real-time monitoring, and cloud-based validation platforms
Increasing demand for transparency and traceability in supply chains
Conducted in a GMP-compliant facility
Critical Process Parameters (CPPs): Granulation time, drying endpoint, compression force
Critical Quality Attributes (CQAs): Uniformity of dosage units, dissolution, stability
Outcome: All three conformance batches met the specifications with low variability
Conducted under ISO 22000:2018 and FSSC 22000 v6 guidelines
Prerequisite Programs (PRPs) validated: Sieving, weighing, blending operations, granulation process, drying parameters, compression force, and sanitation procedures (Validated cleaning and sanitation protocols for equipment and production area, ensuring control of microbial load and allergen contamination)
Label claims verified through both in-house and third-party laboratory testing
Emphasis on sanitation effectiveness, cross-contamination control and allergen management
Documentation of batch manufacturing records and PRP monitoring records maintained as per FSMS requirements
Outcome: Consistent batch conformity observed with verified safety and compliance to declared nutrient content
A comprehensive process validation program is indispensable for ensuring the safety, efficacy, and regulatory compliance of multivitamin tablets. Pharmaceutical-grade validation demands in-depth statistical evaluation, protocol-driven documentation, and lifecycle-based oversight. In contrast, nutraceutical validations emphasize product consistency, food safety, and hygiene practices. Despite the divergent paths, an integrated, risk-based approach that considers scientific principles and global standards can bridge the compliance gap and facilitate robust product development and commercialization.
The authors declare no conflict of interest.
None.